After Bernstein and Credit Suisse gave Cigna (NYSE: CI) a Buy rating last month, the company received another Buy, this time from Oppenheimer. Analyst Michael Wiederhorn maintained a Buy rating on Cigna today and set a price target of $254.00. The company’s shares closed last Wednesday at $195.87.
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 15.2% and a 66.5% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as Community Health, The Ensign Group, and Addus Homecare.
Cigna has an analyst consensus of Strong Buy, with a price target consensus of $244.53.
See today’s analyst top recommended stocks >>
The company has a one-year high of $224.64 and a one-year low of $118.50. Currently, Cigna has an average volume of 2.97M.
Based on the recent corporate insider activity of 94 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CI in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cigna Corp. engages in the provision of global health services. It operates through the following segments: Health Services, Integrated Medical, International Markets, and Group Disability and Other. The Health Services segment includes pharmacy benefits management, specialty pharmacy services, clinical solutions, home delivery, and health management services. The Integrated Medical segment offers a variety of health care solutions to employers and individuals. The International Markets segment covers supplemental health, life and accident insurance products; and health care coverage in its international markets as well as health care benefits to globally mobile employees of multinational organizations. The Group Disability and Other segment represents group disability and life, corporate-owned life insurance, and run-off business consisting of reinsurance; settlement authority; and individual life insurance and annuity and retirement benefits business. The company was founded in 1792 and is headquartered in Bloomfield, CT.
